Genetically engineered stem cell‐derived neurons can be rendered resistant to alpha‐synuclein aggregate pathology.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 3, p. 316, doi. 10.1111/ejn.14333
- By:
- Publication type:
- Article
Works matching IS 0953816X AND DT 2019 AND VI 49 AND IP 3
Results: 12
1
2
Immune system responses in Parkinson's disease: Early and dynamic.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 3, p. 364, doi. 10.1111/ejn.14290
- By:
- Publication type:
- Article
3
The prodromes of Parkinson's disease.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 3, p. 320, doi. 10.1111/ejn.14269
- By:
- Publication type:
- Article
4
The power of the Parkinson's patient according to Tom Isaacs: a call to action.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 3, p. 304, doi. 10.1111/ejn.14211
- By:
- Publication type:
- Article
5
In memory of Tom Isaacs: The epitomical mover and shaker.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 3, p. 303, doi. 10.1111/ejn.14205
- By:
- Publication type:
- Article
6
The unlikely partnership between LRRK2 and α‐synuclein in Parkinson's disease.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 3, p. 339, doi. 10.1111/ejn.14182
- By:
- Publication type:
- Article
7
The Linked Clinical Trials initiative (LCT) for Parkinson's disease.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 3, p. 307, doi. 10.1111/ejn.14175
- By:
- Publication type:
- Article
8
Viewpoint: Developing drugs for levodopa‐induced dyskinesia in PD: Lessons learnt, what does the future hold?
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 3, p. 399, doi. 10.1111/ejn.14173
- By:
- Publication type:
- Article
9
L‐DOPA for Parkinson's disease—a bittersweet pill.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 3, p. 384, doi. 10.1111/ejn.14119
- By:
- Publication type:
- Article
10
Post hoc analysis of the Exenatide‐PD trial—Factors that predict response.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 3, p. 410, doi. 10.1111/ejn.14096
- By:
- Publication type:
- Article
11
The clinical heterogeneity of Parkinson's disease and its therapeutic implications.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 3, p. 328, doi. 10.1111/ejn.14094
- By:
- Publication type:
- Article
12
Issue Information.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 3, p. i, doi. 10.1111/ejn.14024
- Publication type:
- Article